MXPA99011742A - Anhydrous gel deodorant compositions - Google Patents
Anhydrous gel deodorant compositionsInfo
- Publication number
- MXPA99011742A MXPA99011742A MXPA/A/1999/011742A MX9911742A MXPA99011742A MX PA99011742 A MXPA99011742 A MX PA99011742A MX 9911742 A MX9911742 A MX 9911742A MX PA99011742 A MXPA99011742 A MX PA99011742A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- anhydrous gel
- cal
- deodorant
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 171
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 109
- 239000002798 polar solvent Substances 0.000 claims abstract description 34
- 239000003349 gelling agent Substances 0.000 claims abstract description 33
- 239000003205 fragrance Substances 0.000 claims abstract description 32
- 239000002904 solvent Substances 0.000 claims abstract description 22
- 230000001721 combination Effects 0.000 claims abstract description 21
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960003500 triclosan Drugs 0.000 claims abstract description 8
- 238000009835 boiling Methods 0.000 claims abstract description 3
- -1 alkali metal salt Chemical class 0.000 claims description 32
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 24
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 15
- 150000004665 fatty acids Chemical class 0.000 claims description 14
- 150000002430 hydrocarbons Chemical class 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- RYYKJJJTJZKILX-UHFFFAOYSA-M Sodium stearate Chemical group [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N propylene glycol methyl ether Substances COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 3
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 abstract description 30
- ICUTUKXCWQYESQ-UHFFFAOYSA-N Triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 abstract description 4
- 229960001325 triclocarban Drugs 0.000 abstract description 3
- 239000000499 gel Substances 0.000 description 72
- 239000000463 material Substances 0.000 description 18
- 125000000217 alkyl group Chemical group 0.000 description 17
- 235000019645 odor Nutrition 0.000 description 17
- 125000003545 alkoxy group Chemical group 0.000 description 14
- 239000001257 hydrogen Substances 0.000 description 14
- 229910052739 hydrogen Inorganic materials 0.000 description 14
- 125000003118 aryl group Chemical group 0.000 description 13
- 239000012454 non-polar solvent Substances 0.000 description 12
- 125000003342 alkenyl group Chemical group 0.000 description 10
- 125000005907 alkyl ester group Chemical group 0.000 description 10
- 239000002304 perfume Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000000699 topical Effects 0.000 description 10
- 150000002431 hydrogen Chemical class 0.000 description 9
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 150000005215 alkyl ethers Chemical group 0.000 description 7
- 125000004122 cyclic group Chemical group 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 125000002877 alkyl aryl group Chemical group 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 235000013772 propylene glycol Nutrition 0.000 description 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 5
- 230000001166 anti-perspirant Effects 0.000 description 5
- 239000003213 antiperspirant Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000001877 deodorizing Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000000873 masking Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 3
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 3
- 125000001843 C4-C10 alkenyl group Chemical group 0.000 description 3
- 241001445401 Peraxilla Species 0.000 description 3
- 239000011358 absorbing material Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 159000000001 potassium salts Chemical class 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-(4R)-Limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 235000007173 Abies balsamea Nutrition 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000019499 Citrus oil Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N Coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N Decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 244000018716 Impatiens biflora Species 0.000 description 2
- 235000015912 Impatiens biflora Nutrition 0.000 description 2
- SFEOKXHPFMOVRM-BQYQJAHWSA-N Ionone Chemical compound CC(=O)\C=C\C1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-BQYQJAHWSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N Phenethyl alcohol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N Vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000010500 citrus oil Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000004059 degradation Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical class [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 2
- 229960002026 pyrithione Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical class OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3S,3aR,6R,6aR)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 1
- UGSYXNDKIWVIRW-UHFFFAOYSA-N (4-aminophenyl)-naphthalen-1-ylmethanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC2=CC=CC=C12 UGSYXNDKIWVIRW-UHFFFAOYSA-N 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 239000001244 (E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)pent-1-en-3-one Substances 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- VPKMGDRERYMTJX-CMDGGOBGSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1C(C)=CCCC1(C)C VPKMGDRERYMTJX-CMDGGOBGSA-N 0.000 description 1
- ASTZGOKPQNQZHQ-UHFFFAOYSA-N 12-hydroxy-N,N-di(propan-2-yl)octadecanamide Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)N(C(C)C)C(C)C ASTZGOKPQNQZHQ-UHFFFAOYSA-N 0.000 description 1
- KSRYOCHGIAIHRI-UHFFFAOYSA-N 12-hydroxy-N-phenyloctadecanamide Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)NC1=CC=CC=C1 KSRYOCHGIAIHRI-UHFFFAOYSA-N 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N 12-hydroxylauric acid Chemical compound OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N 2,2,4,6,6-pentamethylheptane Chemical compound CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-Butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NFAVNWJJYQAGNB-UHFFFAOYSA-N 2-Methylundecanal Chemical compound CCCCCCCCCC(C)C=O NFAVNWJJYQAGNB-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-Methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- HMKKIXGYKWDQSV-SDNWHVSQSA-N 2-Pentyl-3-phenyl-2-propenal Chemical compound CCCCC\C(C=O)=C/C1=CC=CC=C1 HMKKIXGYKWDQSV-SDNWHVSQSA-N 0.000 description 1
- CCRSXTUSQOIQSX-UHFFFAOYSA-N 2-dodecyl-N,N'-dihexylbutanediamide Chemical compound CCCCCCCCCCCCC(C(=O)NCCCCCC)CC(=O)NCCCCCC CCRSXTUSQOIQSX-UHFFFAOYSA-N 0.000 description 1
- BJRXGOFKVBOFCO-UHFFFAOYSA-N 2-hydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O BJRXGOFKVBOFCO-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methylpentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- UXJMXERXJQAWSP-UHFFFAOYSA-N 2-pentylcyclohexan-1-one Chemical compound CCCCCC1CCCCC1=O UXJMXERXJQAWSP-UHFFFAOYSA-N 0.000 description 1
- ZOZIRNMDEZKZHM-UHFFFAOYSA-N 2-phenylethyl 2-phenylacetate Chemical compound C=1C=CC=CC=1CCOC(=O)CC1=CC=CC=C1 ZOZIRNMDEZKZHM-UHFFFAOYSA-N 0.000 description 1
- YGCZTXZTJXYWCO-UHFFFAOYSA-N 3-phenylpropanal Chemical compound O=CCCC1=CC=CC=C1 YGCZTXZTJXYWCO-UHFFFAOYSA-N 0.000 description 1
- XXBAQTDVRLRXEV-UHFFFAOYSA-N 3-tetradecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCOCCCO XXBAQTDVRLRXEV-UHFFFAOYSA-N 0.000 description 1
- 229940091181 Aconitic Acid Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N Aconitic acid Chemical compound OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- 229960000458 Allantoin Drugs 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 210000001099 Axilla Anatomy 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- HUMNYLRZRPPJDN-UHFFFAOYSA-N Benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 1
- 229960001950 Benzethonium Chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M Benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N Benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 229960002130 Benzoin Drugs 0.000 description 1
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 description 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 1
- 229960000846 Camphor Drugs 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001090476 Castoreum Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229960001927 Cetylpyridinium Chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M Cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N Cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- KSMVZQYAVGTKIV-UHFFFAOYSA-N Decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 1
- 229960003949 Dexpanthenol Drugs 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- FLKPEMZONWLCSK-UHFFFAOYSA-N Diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N Diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- HFJRKMMYBMWEAD-UHFFFAOYSA-N Dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- CRDAMVZIKSXKFV-YFVJMOTDSA-N Farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- 229940043259 Farnesol Drugs 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- GUUHFMWKWLOQMM-NTCAYCPXSA-N Hexyl cinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 1
- 229940078546 ISOEICOSANE Drugs 0.000 description 1
- 229940060367 Inert Ingredients Drugs 0.000 description 1
- VCLJODPNBNEBKW-UHFFFAOYSA-N Isocetane Chemical compound CC(C)(C)CC(C)CC(C)(C)CC(C)(C)C VCLJODPNBNEBKW-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N Itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229940039717 Lanolin Drugs 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229940014456 MYCOPHENOLATE Drugs 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000009136 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241000357291 Monodactylus argenteus Species 0.000 description 1
- 229960000951 Mycophenolic Acid Drugs 0.000 description 1
- UHUFTBALEZWWIH-UHFFFAOYSA-N Myristyl aldehyde Chemical compound CCCCCCCCCCCCCC=O UHUFTBALEZWWIH-UHFFFAOYSA-N 0.000 description 1
- CHSUTCOPDGFQDR-UHFFFAOYSA-N N-benzyl-12-hydroxyoctadecanamide Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)NCC1=CC=CC=C1 CHSUTCOPDGFQDR-UHFFFAOYSA-N 0.000 description 1
- WXLGETGSPUTYNT-UHFFFAOYSA-N N-butyl-12-hydroxyoctadecanamide Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)NCCCC WXLGETGSPUTYNT-UHFFFAOYSA-N 0.000 description 1
- DYUGTPXLDJQBRB-UHFFFAOYSA-N N-myristoylglycine Chemical compound CCCCCCCCCCCCCC(=O)NCC(O)=O DYUGTPXLDJQBRB-UHFFFAOYSA-N 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N Nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N Octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229940114930 POTASSIUM STEARATE Drugs 0.000 description 1
- 229940116987 PPG-3 MYRISTYL ETHER Drugs 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229940067107 Phenylethyl Alcohol Drugs 0.000 description 1
- 241000562356 Polietes Species 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- KQTIIICEAUMSDG-UHFFFAOYSA-N Propane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229940080350 SODIUM STEARATE Drugs 0.000 description 1
- 229940043230 Sarcosine Drugs 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229940045870 Sodium Palmitate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M Sodium laurate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 Sodium laurate Drugs 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 240000008975 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 210000000106 Sweat Glands Anatomy 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N Tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 210000001541 Thymus Gland Anatomy 0.000 description 1
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Chemical compound CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- YAKZEVHORUHNLS-UHFFFAOYSA-K aluminum;sodium;2-hydroxypropanoate;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Na+].[Al+3].[Cl-].CC(O)C([O-])=O YAKZEVHORUHNLS-UHFFFAOYSA-K 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- IUFDGAYUMGNOBT-UHFFFAOYSA-N benzyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC1=CC=CC=C1 IUFDGAYUMGNOBT-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229930007890 camphor Natural products 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000001186 cumulative Effects 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229950008690 docosanoic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
- FAUQJFRSOKONGU-UHFFFAOYSA-N ethyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC FAUQJFRSOKONGU-UHFFFAOYSA-N 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000000855 fungicidal Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229930007090 gamma-ionone Natural products 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- DWYTXBVHIIANQN-UHFFFAOYSA-N hexadecylazanide Chemical compound CCCCCCCCCCCCCCCC[NH-] DWYTXBVHIIANQN-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229930002839 ionones Natural products 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- RVWOWEQKPMPWMQ-UHFFFAOYSA-N methyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OC RVWOWEQKPMPWMQ-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- FTXUQEKXCJSWMO-UHFFFAOYSA-N oxecan-2-one Chemical compound O=C1CCCCCCCCO1 FTXUQEKXCJSWMO-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- NCYDRNOBBHFJHE-UHFFFAOYSA-N propane-1,2-diol;prop-1-ene Chemical group CC=C.CC(O)CO NCYDRNOBBHFJHE-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine zwitterion Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940045845 sodium myristate Drugs 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- CVYDEWKUJFCYJO-UHFFFAOYSA-M sodium;docosanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCCCCC([O-])=O CVYDEWKUJFCYJO-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- MRQYKJNZWPCFNB-UHFFFAOYSA-M sodium;icosanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCCC([O-])=O MRQYKJNZWPCFNB-UHFFFAOYSA-M 0.000 description 1
- JUQGWKYSEXPRGL-UHFFFAOYSA-M sodium;tetradecanoate Chemical compound [Na+].CCCCCCCCCCCCCC([O-])=O JUQGWKYSEXPRGL-UHFFFAOYSA-M 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- SZYJELPVAFJOGJ-UHFFFAOYSA-N trimethylamine hydrochloride Chemical compound Cl.CN(C)C SZYJELPVAFJOGJ-UHFFFAOYSA-N 0.000 description 1
- OFHHDSQXFXLTKC-UHFFFAOYSA-N undec-10-enal Chemical compound C=CCCCCCCCCC=O OFHHDSQXFXLTKC-UHFFFAOYSA-N 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
- LUZDYPLAQQGJEA-UHFFFAOYSA-N Β-Naphthol methyl ether Chemical compound C1=CC=CC2=CC(OC)=CC=C21 LUZDYPLAQQGJEA-UHFFFAOYSA-N 0.000 description 1
Abstract
Disclosed are anhydrous gel deodorant compositions comprising from about 0.001%to about 50%by weight of deodorant active, fragrance, or combination thereof;from about 0.01%to about 20%by weight of a gellant;from about 1%to about 50%by weight of a nonpolar volatile solvent having a solubility parameter of less than 8.0 (cal/cm3)0.5, a vapor pressure of from about 0.01 mm Hg to about 6 mm Hg at 25°C, and a boiling point at 1 atm of less than about 250°C;from about 1%to about 15%by weight of a polar solvent having a solubility parameter of from 12.5 (cal/cm3)0.5 to about 25 (cal/cm3)0.5 and optionally a moderately polar solvent having a solubility parameter of from about 8.0 (cal/cm3)0.5 to less than 12.5 (cal/cm3)0.5, preferably 1,2-hexamediol. Other preferred embodiments include those which contain combinations of triclosan and triclocarban for improved deodorant efficacy. These compositions provide improved performance and skin feel characteristics, and are especially effective at providing deodorant application which is milder to the skin, an improved product clarity.
Description
DEODORANT COMPOSITIONS IN GEL ANHYDRO
FIELD OF THE INVENTION This invention relates to anhydrous gel deodorising compositions containing a non-polar volatile solvent in combination with a polarizing solvent and an active deodorant or fragrance. These compositions are gentle on the skin and cause less irritation to the skin, and have good skin feel characteristics during and after application.
BACKGROUND OF THE INVENTION The odors of the human body are generally believed to be caused in part by microbial interaction with the secretions of the sweat glands that produce acrid fatty acids. In addition to cleaning, one way to control these odors is through the topical application to the armpit of an anti-perspirant or deodorant composition. The deodorant compositions in gel form are especially popular as a means to avoid or mask odors that arise from perspiration. These gel deodorizing compositions are typically in the form of a solid solid or solid stick and, like other antiperspirant or deodorant products, are also applied topically to the underarm or other area of the skin. However, gel deodorants typically glide on the skin more easily than many other antiperspirant or deodorant products, and leave very little visible residue if there is any after the application. These gel deodorants typically contain a gelling agent, a polar solvent to solubilize the gelling agent, and a deodorant active agent such as, for example, an antimicrobial active, perfume or other odor masking material. The gelling agents commonly used in these systems include fatty acid salts, examples of which include sodium or potassium salts of C 2 -C 22 fatty acids. The polar solvents commonly used in combination with the fatty acid salts to form the gel structure of the composition include monohydric or dihydric alcohols, especially ethanol and glycols, such as, for example, propylene glycol, dipropylene glycol and other higher molecular weight propylene glycols. . However, many of these gel deodorants are not gentle on the skin and can cause excessive skin irritation. Therefore, it is an object of the present invention to provide an anhydrous gel deodorant composition which is gentle on the skin and causes less irritation thereto, and furthermore provides a composition which also has good characteristics of the skin. feeling on the skin during and after topical application. Still another object of the present invention is to provide a composition wherein the composition comprises a volatile non-volatile solvent in combination with a polar solvent, and further provide a composition optionally comprising a moderately polar solvent.
BRIEF DESCRIPTION OF THE INVENTION The present invention is directed to anhydrous gel deodorant compositions comprising from about 0.001% to about 50% by weight of a deodorant active, fragrance, or combination thereof; from about 0.01% to about 20% by weight of a gellant; from about 3% to about 50% by weight of a non-polar volatile solvent having a solubility parameter of less than (cal / cm 3) > or .5 a vapor pressure from about 0.01 mm Hg to about 6 mm Hg at 25 ° C; from about 1% to about 15% by weight of a polar solvent having a parameter of __ solubility from 12.5 (cal / cm3) 0"5 to about 25 (cal / cm3) 0.5 and optionally a moderately polar solvent having a solubility parameter from 8.0 (cal / cm3) 0"5 to less than 12.5
(cal / cm or .5) These anhydrous gel deodorant compositions have been found to provide improved performance and skin feel characteristics, and are especially effective in providing a deodorant application that is gentle on the skin and causes less or no skin contact. irritation in it.
c = DETAILED DESCRIPTION OF THE INVENTION The anhydrous gel deodorant compositions of the present invention comprise as essential ingredients a gelling agent, a volatile non-polar solvent, a polar solvent and a perfume or deodorant active. These anhydrous gel deodorant compositions are intended for topical application in the armpit or other suitable areas of the skin. Preferably, the compositions are in the form of solid solid or soft bars, but can also be formulated in a variety of non-stick formulations suitable for application to the armpit or other area of the skin. The term "anhydrous" in the sense in which it is used herein refers to the gel deodorant composition of the present invention, and means that the composition is practically free of water, preferably less than about 5%, more preferably less than about 1%, still more preferably zero percent by weight free of water or water added in the gel deodorant. The term "environmental conditions" in the sense in which it is used herein refers to the surrounding conditions under about a pressure atmosphere, at about 50% relative humidity, and at about 25 ° C. The term "substantially free of aromatic hydrocarbons" in the sense in which it is used herein refers to the anhydrous gel deodorant compositions of the present invention which contain less than about 10%, preferably less than about 5%. % by weight of aromatic hydrocarbons selected from the group of a-pihene, β-pinene, d-limonene and other terpenes. The anhydrous gel deodorant compositions of the present invention may comprise, consist of, or consist essentially of essential elements and limitations of the invention described herein, as well as any other additional or optional ingredients, components, or limitations described in the foregoing. present All the percentages, parts and proportions are by weight of the total composition, unless otherwise specified All weights as they pertain to the ingredients listed are based on the active level and, therefore, they do not include solvents or by-products that can be included in commercially available materials unless otherwise specified.
DEODORANT ACTIVE AND FRAGRANCE _ The anhydrous gel deodorant compositions of the present invention comprise an active deodorant, fragrance or combination thereof, which include deodorant fragrances, at concentrations ranging from about 0.001% to about 50%, preferably from about 20% to about 50%. immaculately 0.01% to about 20%, more preferably from about 0.1% to about 10%, by weight of the composition. These active deodorants and perfumes include any deodorant or fragrance known or otherwise safe and effective for topical application to human skin. Unless otherwise specified, the term "active" in the sense in which it is used herein generally refers to deodorant active or fragrance, while the term "deodorant active" specifically refers to topical materials that they can avoid or eliminate the bad odors that result from perspiration. The term "fragrance" in the sense in which it is used herein, specifically refers to any topical material that covers or masks odors that result from perspiration, or that otherwise provides the composition with the scent of desired perfume.
A) Deodorant Active Deodorant actives suitable for use in the anhydrous gel deodorant composition include any topical material that is known or otherwise effective in preventing or eliminating odors associated with perspiration. These deodorant actives are typically antimicrobial agents (e.g., bacteriocides, fungicides), malodor absorbing material, or combinations thereof. Preferred deodorant actives are antimicrobial agents, non-limiting examples of which include cetyltrimethylammonium bromide, cetyl pyridinium chloride, benzethonium chloride, diisobutyl-1-phenoxy-ethoxy-1-dimethyl chloride. -benzium-ammonium, sodium N-lauryl sarcosine, sodium N-palmitethyl sarcosine, lauroyl sarcosine, N-myristoyl glycine, potassium N-lauryl sarcosine, trimethylammonium chloride, sodium-aluminum chlorhydroxy lactate, citrate -triethyl, tricethyl ethyl ammonium chloride, diphenyl ether of 2,4,4'-t-ricloro-2'-hydroxy (triclosan), 3,4,4'-trichlorocarbanilide (trichlocarbon), diaminoalkyl amides, such as example, hexadecyl amide of L-lysine, heavy metal salts of citrate, salicylate, and pyroctose, especially zinc salts, and acids thereof, heavy metal salts of pyrithione, especially pyrithione de = zinc, zinc phenosulfate , farnesol, and combinations thereof.
-T Preferred deodorant actives are triclosan, cyclocarbon, and co-binders thereof, wherein the preferred concentration of either triclosan or triclocarban ranges from about 0.01% to about 1.0%, more preferably about 0.1%, approximately 0.5%, still more preferred from about 0.1% to about 0.3%, by weight of the composition, and where the total concentration of triclosan and trichlocarbonate when used together in a composition varies from about 0.01% to about 2.0%, of greater preference from about 0.2% to about 1.0%, still more preferably about 0.2% about 0.6%, by weight of the composition. It has been found that the combination of these two active deodorants provides a deodorant efficacy that exceeds the cumulative deodorizing efficacy that one could otherwise predict from that combi_nation. and The preferred combination of triclosan and triclocarban is effective to provide improved deodorant performance from the deodorant compositions described herein, or from any known deodorant or topical composition that contains this combination that is otherwise suitable for application to the human skin. Therefore, the present invention is also directed to a method for controlling the bad odor associated with human perspiration by topically applying the combination of t riclosan / t-cyclocarbon described above, or any other suitable composition containing the triclosan / t-cyclocarbon combination described above, to the armpit or other area of the skin. From most of these deodorant compositions containing this combination, from about 0.1 grams to about 2.0 grams are applied per axilla of the deodorant composition, preferably once or twice a day, most preferably once a day. Other active deodorants include odor absorbing materials, such as, for example, carbonate and bicarbonate salts, which include carbonates and bicarbonates of alkali metal, ammonium and tetraalkylammonium. Sodium and potassium salts of these odor absorbing materials are preferred. Preferably, the anhydrous deodorant composition is practically free of astringent antiperspirant actives, such as, for example, astringent salts or aluminum or zirconium complexes. In this context, the term "practically free" means that the gel deodorant composition preferably contains less than about 5%, more preferably less than about 2%, still more preferably zero percent by weight of the astringent antiperspirant actives.
B) Fragrance Suitable fragrances for use in the anhydrous gel deodorant composition include any topical material that is known or otherwise effective in masking the bad odor associated with perspiration, or which would otherwise provide the composition with the desired perfume aroma. These fragrances include any fragrance perfume or chemical body suitable for topical application to the skin. The concentration of the fragrance in the anhydrous gel composition must be effective to provide the desired flavor characteristics or to "mask the bad odor, where the malodour is inherently associated with the composition itself or is associated with the development of foul odor. Also, the fragrance and all the accompanying carriers should not impart excessive itching to the skin, especially chapped or irritated skin, at the levels previously described.The fragrance will typically be in the form of insoluble perfumes. in water which are solubilized in the anhydrous gel deodorant composition - The fragrances are made by those skilled in the art in a wide variety of fragrances and concentrations.The typical fragrances are described in Arctander, Perfume and Flavor Chemicals (Aroma Chemicals) ^ , Vol. I and II (1969); and Arctander, Perfume and Flavor Materials of Natural Origin (1960). U.S. Patent 4,322,7308 and U.S. Patent 4,304,679, both incorporated herein by reference, describe fragrance components that generally include, but are not limited to: volatile phenolic substances (such as, for example, iso-amyl) salicylate, benzyl salicylate, and thymus red oil); essential oils such as, for example, geranium oil, patchouli oil, and flower oil, petit); citrus oils; extracts and resins (such as, for example, Siamese benzoin resinoid and opoponaco resinoid); "synthetic" oils (such as for example Bergamot 37 and 430, Geranium 76 and Pomeransol 314); aldehydes and ketones (such as by zeje plo, naphthyl ketone of B-methyl, hydrocinnamic aldehyde of p-t-butyl-A-methyl and cyclohexanone of p-t-amyl); polycyclic compounds (such as, for example, coumarin and ß-naphthyl methylether); esters (such as, for example, diethyl phthalate, phenylethyl phenylacetate, nonanolide-1: 4). The fragrances also include esters and essential oils derived from floral materials and fruits, citrus oils, pure aldehydes, resinoids, notes of musk and other animals (for example, natural isolates of civet, castoreum and musk), balsams, etc. , and alcohols (such as, for example, dimyrcetol, phenylethyl alcohol and tet rahidromuguol). Examples of these useful components in the fragrances herein include decyl aldehyde, undecyl aldehyde, undecylenic aldehyde, lauric aldehyde, amyl cinnamic aldehyde, phenyl methyl ethyl glycidate, nonyl methyl acetaldehyde, myristic aldehyde, nonalactone, nonyl aldehyde, aldehyde octyl, undecalactone, hexyl cinnamic aldehyde, benzaidehyde, vanillin, heliot garniture, camphor, para-hydroxy phenolbutanone, tetrahydronaphthalene of 6-acetyl 1,1,3,4,4,6 hexamethyl, alpha-methyl ionone, gamma-ionone ionone , and amyl-cyclohexanone, and mixtures of these components. Other suitable fragrances are those which mask or help to mask odors associated with perspiration (hereinafter referred to as odor-masking fragrances), some non-limiting examples thereof are described in U.S. Patent 5,554,588, U.S. Patent 4,278,658, U.S. Patent 5,501,805, and Patent Application EP 684 037 Al, all are incorporated herein by reference 'in their entirety. Preferred odor masking fragrances are those having a Deodorizing Value of at least about 0.25, more preferably from about 0.25 to about 3.5, still more preferably from 0.9 to about 3.5, as "measured by the Deodorant Value Test described. in the patent application EP 684 037 Al. - The fragrance for use herein may also contain solubilizers, diluents or solvents which are well known in the art These materials are described in Arctander, Perfume and Flavor Chemicals (Aroma Chemicals ), Vol. I and II (1969) These materials typically include dipropylene glycol, diethylene glycol, Ci-Ce alcohols, and benzyl alcohol.
"Gelifier" ~ The anhydrous gel deodorant composition of the present invention comprises a gelling agent suitable for providing the desired strength and application characteristics to the composition.The gelling concentrations vary from about 0.01% to about 20%, preferably about 0.1% to about 10%, more preferably from about 1% to about 8%, still more preferably from about 3% to about 7%, by weight of the anhydrous gel deodorant composition, any gelling agent or gelling system can be used known in the anhydrous gel deodorant composition of the present invention with the proviso that the selected gelling agents can be melted and form a solution or other homogeneous liquid or liquid dispersion with the selected solvent system described herein at a about 50 ° C to about 150 ° C, of p reference of approximately 50 ° C to approximately
120 ° C, more preferably from about 60 ° C to about 100 ° C. The selected gelling agent must also provide the gel deodorant composition with the desired gel matrix after the formulation and at the end of processing which then gives the composition the strength or spreading characteristics. Preferred gelling agents for use in the anhydrous gel deodorant composition of the present invention are salts of fatty acids, in
_ i = where the fatty acid portion has from about 12 to about 40 carbon atoms, preferably from about 12 to about 22 carbon atoms, more preferably from about 16 to about 20 carbon atoms, still more preferred of about 18 carbon atoms Suitable salt cations for use with these gelling agents include metal salts such as alkali metals, for example, sodium and potassium, and alkaline earth metals, for example, magnesium and aluminum. the sodium and potassium salts, more preferably sodium stearate, sodium palmitate, sodium laurate, sodium arachidate, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, aluminum monostearate, and combinations thereof. Non-limiting examples of fatty acids suitable for producing gelling agents are most preferred. of fatty acid, include acids, such as for example, irythic, palmitic, stearic, oleic, lauric, arachidic, behenic, linoleic, linolenic, margaric and combinations thereof. These fatty acids are preferably derived from sources, such as, for example, coconut oil, beef tallow, lanolin, fish oil, beeswax, palm oil, peanut oil, olive oil, oil of s.emilla. of cotton, soybean oil, corn oil, rapeseed oil, colony acids, fats and other natural sources, or are derived by synthetic or semi-synthetic methods well known to those skilled in the art of the formulation. Other gelling agents suitable for use in the anhydrous gel deodorant composition include hydroxy acids, fatty acids, fatty acid esters and fatty acid salts, fatty hydroxy fatty acids, spherical materials, lanolinol materials, and other amide gelling agents known to be used as agents. gelling agents or otherwise are described in detail hereinafter. Non-limiting examples of suitable fatty acid gelling agents include fatty acid and hydroxy acids or alpha hydroxy fatty acids, having from about 10 to about 40 carbon atoms, examples of which include 12-hydroxy-aroic acid, 12-hydroxylauric acid, 16-hydroxy acid hydroxyhexadecanoic, behenic acid, euricic acid, stearic acid, caprylic acid, lauric acid, isoesteric acid, combinations thereof, and salts thereof. Other non-limiting examples of specific gelling agents suitable for use in the anhydrous gel deodorant composition include those corresponding to the following formula:
wherein Rx is 0R2 or NR2R3; and R 2 and R 3 are hydrogen, or an alkyl, aryl, or arylalkyl radical that is linear or branched or cyclic and has from about 1 to about 22 carbon atoms; preferably "from about 1 to about 18 carbon atoms. R2 and R3 may be either the same or different; however, preferably, at least one is a hydrogen atom. Among these gelling agents are those selected from the group consisting of 12-hydroxystearic acid, 12-hydroxystearic acid methyl ester, 12-hydroxystearic acid ethyl ester, and 12-hydroxystearic acid benzylester of 12-hydroxyl acid. Theoretical, 12-hydroxyl tearic acid amide, 12-hydroxyl isopropyl tetraric acid amide, 12-hydroxystearic acid butylamide, 12-hydroxystearic acid benzylamide, 12-hydroxystearic acid phenylamide, 12-hydrohydroxyxysteic acid tert-butylamide 12-hydroxystearic acid cyclohexylamide, 1-adamant 12-hydroxystearic acid ilamide, 2-adamant 12-hydroxystearic acid ilamide, 12-hydroxystearic acid diisopropylamide, and mixtures thereof Suitable non-limiting examples of amide gelling agents for use in the anhydrous gel deodorant composition, include disubstituted monoamide gelling agents or greases, gelling agents of monosus r thalide or branched gels, triamide gelling agents, and combinations thereof. Preferred are the alkyl amides of the di- and / or tri-basic carboxylic acids or anhydrides which are in accordance with the formula:
I9 II I5 C N R.
. ^ ° ?? 11: - c - N 1 1 10
wherein a structure is formed from the bond of C ', C "and X and where a) Rx is null, hydroxy, hydrogen, aryl, siloxane or C 1 -C 22 alkyl, C 1 -C 22 alkenyl, C? -C22, C1- C22 alkyl alkylethers, straight chain, branched or cyclic, substituted or unsubstituted, saturated or unsaturated, C1-C22 alkyl substituted, preferably C1-C22 alkyl, C4-18, C4-C18 alkenyl, C4-C18 alkoxy, C4-C18 alkyl esters, C4-C18 alkyl ethers, or aryl substituted with C4-C18 alkyl, more preferably C12-C? 8 alkyl, C 12 -C 18 alkenyl, C 2 -C 8 alkoxy, C 2 -C 8 alkylaryl, C 12 -C 18 alkylethers, or C 12 -C 18 alkyl substituted aryl; b) R 2, R 4, R5 and Re. Are independently or together, hydrogen, hydroxy, aryl, siloxane or C?-C22 alkyl, C?-C22 alkenyl, C?-C22 alkoxy, C alqu-C¡2 alkyl alkylesters C? -C22, straight chain, branched or cyclic substituted in substituted, saturated or unsaturated, or aryl substituted with Ci-C22 alkyl, preferably C4-C10 alkyl, C4-C10 alkenyl, C4-C10 alkoxy, C4-C10 alkylester, C4-C10 alkyl ether, or aryl substituted with C 4 -C 10 alkyl, more preferably C 4 -C 8 alkyl, C 4 -C 8 alkenylp, C 4 -C 8 alkoxy, C 4 -C 8 alkyl esters, C 4 -C 8 alkylethers, or C 1 -C 8 alkyl substituted aryl C8; c) R3 is null, hydroxy, hydrogen, C1-C4 alkyl, alkenyl of _C? -C4, C1-C4 alkoxy, C? -C4 alkyl esters or straight chain, branched or cyclic C1-C4 alkyl ethers, substituted or unsubstituted, saturated or unsaturated, preferably a C3-C4 alkoxy, hydroxy or hydrogen, more preferably a hydroxy or hydrogen; d) R7 and R8 are independently or jointly, null, hydrogen, hydroxy, aryl, siloxane or C? -C2 alkyl, C? -C22 alkenyl, C? -C22 alkoxy, C? -C22 alkyl esters, alkyl ethers of straight-chain, branched or cyclic C-C22, substituted or unsubstituted, saturated or unsaturated, or aryl substituted with C 1 -C 22 alkyl, preferably C 4 -C 10 alkyl, C 4 -C 10 alkenyl, C 4 alkoxy C10, C4-C10 alkylesters, C4-C10 alkyl ethers, or aryl substituted with C4-C10 alkyl, more preferably C4-C8 alkyl, C4-C8 alkenyl, C4-C8 alkoxy, C4-C8 alkylesters , C4-Cs alkyl ethers, or aryl substituted with C4-C8 alkyl; e) R9 is zero or hydrogen; f) Rio and R11 are independently or jointly, null, hydrogen, hydroxy, aryl, siloxane or C? -C6 alkyl, alkenyl d? C? -C6, C? -C6 alkoxy, Ci-Ce alkyl esters, alkyl ethers of straight-chain, branched or cyclic C6-C6, substituted or unsubstituted, saturated or unsaturated, or aryl substituted with C6-C6 alkyl, preferably C1-C4 alkyl, C1-C4 alkenyl, C1 alkoxy -C4, C1-C4 alkyl esters, C1-C4 alkyl ethers, aryl substituted with C1-C4 alkyl or hydrogen, more preferably hydrogen; g) X is zero, nitrogen, aryl or -CH n where n is an integer from 1 to 6, preferably -fCH2-H? where n is an integer from 1 to 3; h) Y is zero, acyl or carbonyl; i) Z is zero, hydrogen, hydroxy, aryl, siloxane, nitrogen or C 1 -C 22 alkyl, C 1 -C 22 alkenyl C 1 -C 22 alkoxy / _ C 1 -C 22 alkylesters / C 1 -C 12 chain alkylethers straight, branched or cyclic, substituted or unsubstituted, saturated or unsaturated, or aryl substituted with C 1 -C 22 alkyl, preferably C 4 -C 10 alkyl, C 4 -C 10 alkenyl, C 4 -C 10 alkoxy, C 4 alkylester C10, C4-C10 alkyl ethers, or aryl substituted with C4-C3.0 alkyl, more preferably C4-C8 alkyl, C4-C8 alkenyl, C4-C8 alkoxy, C4-C8 alkyl esters, C-alkyl ethers -C8, or aryl substituted with C4-C8 alkyl; and _3 j) "a" is a double or single bond with the condition that: _ (i) when X is null, Y, Z, R3, R7 and R8 are null, C1 is directly connected to C "and Rx is not a hydrogen, (ii) when X and Z are not null and Y is zero, X is directly bonded to Z;
~ (iii) when Z is zero, a hydrogen or a hydroxy, R7 and Rs are zero; and (iv) when "a" is a double bond, R3 and R9 are "non-limiting." Non-limiting examples of specific alkyl amide gelling agents suitable for use in the anhydrous gel deodorant composition include alkyl amides of citric acid, tricarballylic acid. , aconitic acid, nitrilotriacetic acid, succinic acid, and itaconic acid, such as, for example, tributyl ilamide 1,2,3-propsrho, tributylamide 2-hydroxy-l, 2,3-propane, 1-propen-1,2 , 3-trioctylamide, N, N ', N "-tri (acetodecyla ida) amine, 2-dodecyl-N, N'-dihexylsuccinamide, and 2 -dodecyl-N,' -dibutylsuccinamide.
Volatile Non-Polar Solvent The anhydrous gel deodorizing compositions of the present invention comprise a volatile non-polar solvent having selected solder, vapor pressure and solubility parameter. The concentration of the volatile non-polar solvent in the anhydrous gel deodorant composition would range from about 1% to about 50%, preferably from about 10% to about 40%, most preferably from 20% to about 40%, still of higher preference from about 30% to about 40% by weight ~ of the composition. The term "volatile", in the sense in which it is used herein, refers to the volatile non-polar solvent of the anhydrous gel deodorant composition of the present invention, and in this context specifically refers to non-polar solvents having a vapor pressure as measured at 25 ° C from about 0.01_mmHg to about 6mmHg, preferably from about 0.02mmHg to about 1.5mmHg, and an average boiling point at a pressure atmosphere (1 atm) of less than about 250 ° C, preferably less than about 235 ° C, at 1 atmosphere (atm) of pressure. The term "non-polar", in the sense in which it is used herein, refers to the volatile non-polar solvent of the anhydrous gel deodorant composition of the present invention, and in this context specifically refers to non-polar solvents. volatiles that have a solubility parameter of less than
0 (cal / cm3) 0.5 preferably of about 5.0 (cal / cmJ) 0.5 less than 8.0 (cal / cm) u, most preferably 6.0 (cal / cm3) 0-5 to about 7.60
(cal / cm3) 0-5. The solubility parameters for the volatile non-polar solvent and other materials described herein are determined by methods well known in the chemical arts to establish the relative polar character of a solvent or other material. A description of the solubility parameters and the means to determine them are described by C.D. Vaughan, "Solubility Effects in Product, Package, Penetration and Preservation" 103 Cosmetics and Toiletries 47-69, October 1988; and C.D. Vaughan, "Using Solubility Parameters in Cosmetics Formula", 36 J. Soc. Cosmetic Chemists 319-333, September / October 1988, the descriptions of which are incorporated herein by reference. Volatile non-polar solvents suitable for use in anhydrous gel deodorant compositions are those solvents having the vapor pressure and the solubility parameters described above, which may also include hydrocarbons, esters, amides, and ethers having the vapor pressure and the required solubility parameter. Preference is given to non-polar hydrocarbon solvents which may be cyclic, branched or chain configurations, more preferably branched chain hydrocarbons. More preferably, the volatile non-polar solvent is a branched chain hydrocarbon having the required vapor pressure and solubility parameter and having from about 4 to about 30 carbon atoms, preferably from about 4 to about 20 carbon atoms. carbon, more preferably from about 6 to about 20 carbon atoms. The most preferred anhydrous gel deodorant composition comprises a combination of two or more of the branched chain hydrocarbons described in the foregoing., e ~ n where the combination of two more hydrocarbons have different molecular weights, number of carbon atoms, and / or chain configurations. Specific non-limiting examples of these more preferred combinations of hydrocarbon solvents include the isoparaffins available from Exxon Chemical Company, Bayto n, Texas USA, as Isopár M (isoparaffin "of C? 3-C? 4), Isopar C (Isoparaffin of C7) -C8), C8-C9 Isoparaffin (Isopar E), Isopar G (Cio-n Isoparaffin), Isopar L (C11-C13 Isoparaffin) and Isopar H (C11-C12 Isoparaffin) Other non-limiting examples of hydrocarbons Suitable branched chain include Permethyl 99A (isododecane) Permethyl 102A (isoeicosane), Permethyl 101A (isohexadecane), combinations of the same, Permethyl series are available from Preperse, -Inc., South Plainfield, New Jersey, USA Other non-limiting examples of suitable branched chain hydrocarbons include petroleum distillates, such as, for example, those available from Phillips Chemical such as Soltrol 130, Soltrol 170, and those available from Shell as Shell Sol 70, -71, and -2033.
"Non-limiting examples of other non-polar volatile solvents suitable for use in the anhydrous gel deodorant composition include dibutyl adipate, diisopropyl adipate, dodecane, octane, decane and combinations thereof. Yet another example includes C11 alkanes / cycloalkanes. -C15 available from Exxon as Exxsol D80.
Polar Solvent; The anhydrous gel deodorant composition of the present invention comprises one or more polar solvents having a selectively high solubility parameter. The concentration of the polar solvent in the anhydrous gel deodorant gel composition will vary with the specific polar polarization, gelling, and other optional solvents in the composition, although it should not exceed about 15% by weight of the composition, preferably from about 0.5% to about 10%, more preferably from about 1% to about 8%, still "more preferably from about 3% to about 7% by weight of the dehydrating composition in anhydrous gel, wherein the polar solvent has a solubility parameter of at least 12.5 (cal / cm3) 0.5, preferably 12.5
(cal / cm3) 0-5 to about 25 (cal / cm3) 0-5, most preferably 12.5 (cal / cm3) 0-5 to about 17.0
(cal / cm3) ° -5.
Non-limiting examples of polar solvents suitable for use in the anhydrous gel deodorant composition include monohydric alcohols, polyhydric alcohols, and combinations thereof, examples of which include monohydric alcohols of _C? to C2o preferably monohydric alcohols of C2 to Cs, and propylene glycols and polyethylene glycols having from 2 to 7 repeating ethoxylate or propoxylate groups, and polyglycerols having from 2 to 16 repeating glycerol moieties. Specific examples of polar solvents suitable for use in the anhydrous gel deodorant composition include, but are not limited to: glycerin, propylene glycol, dipropylene glycol, ethanol, water, tertropylene glycol, butyl glycol, propylene glycol methyl ether, dipropylene glycol methyl ether, and combinations thereof . Glycerin is more preferred. The deodorant gel compositions of the present invention are preferably substantially free of propylene glycol, dipropylene glycol, or combinations thereof. In this context, the term "practically free" means that the compositions preferably contain less than 20%, more preferably less than 10%, still more preferably zero per cent, by weight of propylene glycol, dipropylene glycol, or combinations thereof. . A preferred embodiment of the anhydrous gel deodorant composition of the present invention is that which comprises g? Icerin as the polar solvent "and a metal salt of a fatty acid as defined herein as the gellant, wherein the proportion by weight from glycerin to fatty acid salt "is from about 0.5: 1 to about 3: 1, preferably from about 0.8: 1 to about 1.5: 1. It has been found that this narrow proposal of glycerin to fatty acid salt in the anhydrous gel deodorant composition allows the formulation of a sufficiently hard gel rod to be formulated or processed using sufficiently low process temperatures to minimize or eliminate the thermal degradation of the materials sensitive to heat in the composition. The combinations of sodium stearate and glycerin are more preferred. Another embodiment of the anhydrous gel deodorant composition of the present invention is that which comprises a fatty acid or hydroxy acid fatty acid gellant as described herein, in the anhydrous gel deodorant composition also described herein. Unlike all other embodiments of the anhydrous gel deodorant compositions of the present invention, these compositions may contain but not require the use of polar solvents and preferably contain less than 5%, more preferably less than 2%. , still more preferably less than 0.1%, by weight of these polar solvents. = "~~ = Other non-limiting examples of polar solvents which may be suitable for use herein are described in U.S. Patent 5,429,816; Cosmetics, "Science, and Technology, Vol 1, 27-104, edited by Balsam and Sagarin (1972), U.S. Patent 4,202,879, and U.S. Patent 4,816,261, the disclosures of which are incorporated herein by reference .
Moderately Polar Solvent The anhydrous gel deodorant composition of the present invention may further comprise one or more moderately polar solvents having a selectively moderate solubility parameter. This optional solvent is used in the anhydrous gel deodorant composition in addition and in combination with the polar solvent described above. The moderately polar solvent helps to reduce the syneresis of the anhydrous gel deodorant composition during storage for shipping or for a long time, especially when shipping or storage is carried out in hot climates or under hot storage conditions. The moderately polar solvent also helps reduce the process temperatures that can cause thermal degradation of fragrances or other similar materials in the anhydrous gel deodorant composition. The moderately polar solvent comprises one or more solvents having a solubility parameter from about 0 (cal / cm3) 0.5 less than 12.5 (cal / cm 3.0.5 preferably from about 9.0 to less than 12.5 (cal / cm3 or .5 , wherein, the concentration of the moderately polar solvent in the anhydrous gel deodorant composition preferably ranges from about 0.1% to about 40%, more preferably from 5% to about 30%. "The selection of specific concentrations for a solvent moderately polar will vary depending on the other selected solvents and gelling agents in the anhydrous gel deodorant composition - Non-limiting examples of moderately polar solvents suitable for use in the anhydrous gel deodorant composition include ethoxylated ethers of fatty alcohols having from about 8 to about 30 carbon atoms, esters of polyhydric alcohols, esters of fatty acids, poliet ilenglicoles having at least 8 ethoxylated groups, - polypropylene glycols having at least 8 propoxylated groups, non-polymeric diols having at least 4 carbon atoms, and combinations thereof. Specific non-limiting examples of moderately polar solvents suitable for use in the gel deodorant composition include monoes is propylene glycol propylene; mycophenolate PPG-3; PEG-8; hexylene glycol; 1,2, hexanediol; 1,2-butyl ether, PPG-14, dimethyl isosorbide, and combinations thereof. Preferred are hexylene glycol, PPG-3 myristyl ether, propylene glycol monoisostearate, 1,2-hexanediol, and combinations thereof! It has been found that anhydrous gel deodorant compositions containing 1,2-hexanediol are especially effective in providing improved product clarity and improved softness when applied topically to the skin.
Optional Ingredients The anhydrous gel deodorant compositions of the present invention may further comprise one or more optional components that may modify the physical, chemical, cosmetic or aesthetic characteristics of the compositions or may serve as additional "active" components when deposited on the skin. . The compositions may also comprise optional inert ingredients. Many of these optional ingredients are known to be used in deodorants or other personal care compositions and may also be used in the anhydrous gel deodorant compositions herein, with the proviso that these optional materials are compatible with the materials. essentials described herein, or that do not otherwise unduly damage the performance of the product.
Non-limiting examples of optional ingredients suitable for use in the anhydrous gel deodorant composition herein include pH regulating agents; additional emollients; humectants; appeasing agents; dyes and pigments; medications, conservatives; and soothing agents such as, for example, aloe vera, allantoin, D-panthenol, avocado oil and other vegetable oils, and lichen extract.
MANUFACTURING METHOD 2. The compositions of the present invention can be made by any of the methods known in the art for the formulation of the deodorant gel compositions. As will be apparent to those skilled in the art, the particular method will depend on the selection of the specific types and amounts of the components employed. In general, the compositions of the present invention can be prepared by mixing the polar solvent, the volatile non-polar solvent, the deodorant active and any other optional solvents. Adding the gellant with stirring and heating the mixture to a temperature from about 75 ° C to about 100 ° C allows the gellant to melt and form a virtually clear or translucent liquid. The resulting solution is cooled beforehand, the fragrance added (if applicable), and then the cooled composition is emptied into an appropriate container or dispenser at about 70 ° C and allowed to solidify inside the container or dispenser upon cooling or allowing the contained composition is cooled to room temperature.
METHOD OF USE The anhydrous gel deodorant composition of the present invention can be applied topically to the skin by any known method or otherwise effective to control the malodor associated with perspiration. These methods comprise applying to the armpit or other area of the human skin a safe and effective amount of the anhydrous gel deodorant composition of the present invention. In this context, the term "safe and effective amount" means an amount of the anhydrous gel deodorant composition applied topically to the skin which is effective in masking, reducing or eliminating the odor associated with human perspiration while being safe for human use at a reasonable risk / benefit ratio. In this context, a safe and effective amount typically ranges from about 0.1 grams per armpit to about 2.0 grams per-axilla. The compositions are preferably applied to the armpit or other area of the skin once or twice a day, preferably once a day.
EXAMPLES The following examples illustrate specific embodiments of the anhydrous gel deodorant compositions of the present invention, including methods of manufacture and use, but are not intended to be limiting thereof. Other modifications may be attempted by the skilled artisan without departing from the spirit and scope of this invention. Each of the exemplified compositions are prepared by combining all the listed components, except for the gellant and the fragrance where applicable, and heating with stirring the combination of the ingredients at a temperature per the packing point of the melting point but less than 110. ° C. The gelling agent is then added while continuing the heating and stirring of the mixture until a substantially clear or translucent liquid results, at which point the liquid is cooled to a temperature of between 69 ° C and 73 ° C. The fragrance is added with agitation to the cooled liquid. The liquid containing the fragrance is then emptied into an appropriate distributor or other container and allowed to solidify by cooling to room temperature.
Table 1
The resulting compositions described in Tables 1 to 4 are gel deodorants which can then be applied topically to the axilla in an amount ranging from about 0.1 grams to about 2 grams per axilla. The applied compositions are effective to reduce, mask or eliminate the odor of perspiration, and have good skin feel characteristics during and after application. The applied compositions are gentle on the skin and cause little or no skin irritation. All exemplified amounts are percentages by weight per weight based on the total weight of the composition, unless otherwise specified.
Claims (10)
- CLAIMS: 1. An anhydrous gel deodorant composition characterized in that it comprises: (a) from 0.001% to 50% by weight of active deodorant, fragrance, or combination thereof; (b) from 0.01% to 20% by weight of a gelling agent; (c) from 1% to 50% by weight of a non-polar volatile solvent having a solubility parameter of less than 8.0 (cal / cm 3) 0.5, a vapor pressure from 0.01 mm Hg to 6 mm Hg at 25 ° C, and an average boiling point of less than 250 ° C; and (d) from 1% to 15% by weight of a polar solvent that "has a solubility parameter from 12.5 to 25 (cal / cm3) ° '.
- 2. The anhydrous gel deodorant composition according to Claim 1, characterized in that the composition contains less than 1% by weight of water, and wherein the gellant is an alkali metal salt of fatty acid having from 12 to 22 carbon atoms. carbon.
- 3. The anhydrous gel deodorant composition according to any of the preceding Claims, characterized in that the non-polar volatile solvent is a volatile branched chain hydrocarbon having from 4 to 40 carbon atoms.
- 4. The anhydrous gel deodorant composition according to Claim 3, characterized in that the composition comprises a combination of two or more volatile branched chain hydrocarbons having different molecular weights, each of which also has from 6 to 20 carbon atoms .
- 5. The anhydrous gel deodorising composition according to claim 4, characterized in that the volatile branched chain hydrocarbon is selected from the group consisting of C13-C14 isoparaffin, C-C8 isoparaffin, Cs-Cg isoparaffin, isoparaffin of C10-Cn, isoparaffin of Cn-C? 3, isoparaffin of n-12, and combinations thereof.-
- 6. The anhydrous gel deodorant composition, according to any of the preceding indications, characterized in that the polar solvent is selected from the group consisting of glycerin, propylene glycol, dipropylene glycol, ethanol, ripropylene glycol, butylene glycol, propylene glycol methyl ether, dipropylene glycol methyl ether. , and combinations thereof.
- 7. The anhydrous gel deodorant composition according to any of the preceding claims, characterized in that the polar solvent comprises glycerin, the fatty acid salt is sodium stearate and the weight ratio of glycerin to sodium stearate is 0.8: 1 to 1.5: 1.
- 8. The dehydrating composition in anhydrous gel, according to any of the preceding claims, characterized in that the deodorant active is selected from the group consisting of 0.01% to 1.0% Ten weight of triclocarbano, from 0.01% to 1.0% by weight of triclosan, and from 0.02% to 2.0% by weight of any combination thereof.
- 9. The anhydrous gel deodorant composition according to any of the preceding claims, characterized in that the composition further comprises 0.1% to 40% by weight of a moderately polar solvent having a solubility parameter of 8.0 (cal / cm3) 0 ' 5 to less than 12.5 (cal / cm3) 0-5.
- 10. The anhydrous gel deodorant composition according to claim 9, characterized in that the moderately polar solvent comprises 1,2-hexanediol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/880,939 | 1997-06-23 | ||
US09071106 | 1998-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99011742A true MXPA99011742A (en) | 2000-06-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5902572A (en) | Anhydrous gel deodorant compositions | |
JP3188463B2 (en) | Antiperspirant gel stick composition | |
US4759924A (en) | Cosmetic sticks | |
EP1073409B1 (en) | Deodorant compositions containing 1,2-hexanediol | |
US4822602A (en) | Cosmetic sticks | |
EP0512770B1 (en) | Clear gelled cosmetic compositions and process for production | |
AU727783B2 (en) | Cosmetic gel composition having reduced skin irritation | |
KR20010043228A (en) | Antiperspirant compositions containing 1,2-hexanediol | |
MX2008012154A (en) | Hydrogenated castor oil based compositions as a replacement for petrolatum. | |
KR20020033770A (en) | Compositions containing solubilized, acid-enhanced antiperspirant active | |
EP0386900A2 (en) | Deodorant compositions containing specific piroctone salts and perfumes | |
US6174521B1 (en) | Gel deodorant compositions having reduced skin irritation | |
WO1998058625A1 (en) | Gel deodorant compositions having reduced skin irritation | |
WO2002013776A2 (en) | Method of providing improved deodorant application to the underarm | |
WO1998058624A1 (en) | Anhydrous gel deodorant compositions containing volatile nonpolar solvents | |
MXPA02007964A (en) | Low tack cosmetic composition sticks. | |
US6096298A (en) | Deodorant compositions containing isopropyl glycerol ether | |
RU2212228C2 (en) | Cosmetic composition causing weak skin irritation | |
MXPA02002004A (en) | Compositions containing solubilized antiperspirant active. | |
MXPA99011742A (en) | Anhydrous gel deodorant compositions | |
MXPA00000073A (en) | Anhydrous gel deodorant compositions containing volatile nonpolar solvents | |
MXPA99011743A (en) | Gel deodorant compositions having reduced skin irritation | |
MXPA00010755A (en) | Deodorant compositions containing 1,2-hexanediol | |
MXPA98001358A (en) | Composition of cosmetic gel having irritation of skin reduc |